The Latest Breaking News from Nasdaq

A new game is bringing the World of Warcraft franchise to mobile users. Here’s what investors and gamers should know about the Activision Blizzard (NASDAQ: ATVI) announcement.

Stephens has reiterated an Overweight rating for Apollo Endosurgery Inc (NASDAQ:APEN) while increasing the price target from $8 to $9. "In our opinion, APEN's valuation does not assign full value to the promising ESS business or targeted opportunities for expanded device utilization and enhanced reimbursement longer term," says Stephens. The revision follows APEN's above…

Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.

The Dow Jones rallied over 2% in late-afternoon trading after the Fed's rate hike announcement triggered a broad-market rally.

Cemtrex Inc (NASDAQ:CETXP) looked to a strategic shift towards prioritizing its core businesses, notably Vicon Industries, its security technology brand.  Cemtrex explored the divestiture of one or more business units to bolster its Advanced Technologies segment. Cemtrex saw untapped potential in its security business, Vicon, with escalating demand as end-users seek a reliable source…

RCI Hospitality Holdings Inc (NASDAQ:RICK) has launched Rick's Steakhouse and Lounge at Scarlett's Cabaret Miami. Rick's Steakhouse will offer high-end dining and an upscale lounge, aiming to bring the Rick's Cabaret New York experience to South Florida. The 3,000 square foot Rick's Steakhouse and Lounge can seat up to 150. In addition to…

Shares of several companies in the broader technology sector, including Microsoft Corporation (NASDAQ: MSFT), are trading higher amid overall market strength after the Federal Reserve announced it would raise the key interest rate by 50 basis points.

Trivago N.V. (NASDAQ: TRVG) has traded lower since reporting financial results on Monday despite the company's optimism surrounding travel trends. 

Oyster Point Pharma (NASDAQ:OYST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oyster Point Pharma will report an earnings per share (EPS) of $-1.74.